712 related articles for article (PubMed ID: 12719570)
1. Comparison of adjuvant efficacy of herpes simplex virus type 1 recombinant viruses expressing TH1 and TH2 cytokine genes.
Osorio Y; Ghiasi H
J Virol; 2003 May; 77(10):5774-83. PubMed ID: 12719570
[TBL] [Abstract][Full Text] [Related]
2. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.
Osorio Y; Ghiasi H
J Virol; 2005 Mar; 79(6):3297-308. PubMed ID: 15731224
[TBL] [Abstract][Full Text] [Related]
3. An M2 Rather than a T
Lee DH; Ghiasi H
J Virol; 2018 May; 92(10):. PubMed ID: 29491152
[TBL] [Abstract][Full Text] [Related]
4. Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-gamma driven by the LAT promoter.
Ghiasi H; Osorio Y; Hedvat Y; Perng GC; Nesburn AB; Wechsler SL
Virology; 2002 Oct; 302(1):144-54. PubMed ID: 12429523
[TBL] [Abstract][Full Text] [Related]
5. Improvement of herpetic stromal keratitis with fumaric acid derivate is associated with systemic induction of T helper 2 cytokines.
Heiligenhaus A; Li H; Schmitz A; Wasmuth S; Bauer D
Clin Exp Immunol; 2005 Oct; 142(1):180-7. PubMed ID: 16178874
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of interleukin-2 by a recombinant herpes simplex virus type 1 attenuates pathogenicity and enhances antiviral immunity.
Ghiasi H; Osorio Y; Perng GC; Nesburn AB; Wechsler SL
J Virol; 2002 Sep; 76(18):9069-78. PubMed ID: 12186890
[TBL] [Abstract][Full Text] [Related]
7. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
[TBL] [Abstract][Full Text] [Related]
8. Enhanced clearance of herpes simplex virus type 1 and reduced herpetic eye disease in STAT6 knockout mice is associated with increased IL-2.
Ghiasi H; Osorio Y; Nesburn AB; Wechsler SL
Virology; 2002 Oct; 302(2):286-93. PubMed ID: 12441072
[TBL] [Abstract][Full Text] [Related]
9. The role of T(H)1 and T(H)2 cytokines in HSV-1-induced corneal scarring.
Osorio Y; Sharifi BG; Perng G; Ghiasi NS; Ghiasi H
Ocul Immunol Inflamm; 2002 Jun; 10(2):105-16. PubMed ID: 12778346
[TBL] [Abstract][Full Text] [Related]
10. Conjunctival macrophage-mediated influence of the local and systemic immune response after corneal herpes simplex virus-1 infection.
Bauer D; Schmitz A; Van Rooijen N; Steuhl KP; Heiligenhaus A
Immunology; 2002 Sep; 107(1):118-28. PubMed ID: 12225370
[TBL] [Abstract][Full Text] [Related]
11. The role of interleukin (IL)-2 and IL-4 in herpes simplex virus type 1 ocular replication and eye disease.
Ghiasi H; Cai S; Slanina SM; Perng GC; Nesburn AB; Wechsler SL
J Infect Dis; 1999 May; 179(5):1086-93. PubMed ID: 10191208
[TBL] [Abstract][Full Text] [Related]
12. CD8+-dependent CNS demyelination following ocular infection of mice with a recombinant HSV-1 expressing murine IL-2.
Osorio Y; La Point SF; Nusinowitz S; Hofman FM; Ghiasi H
Exp Neurol; 2005 May; 193(1):1-18. PubMed ID: 15817260
[TBL] [Abstract][Full Text] [Related]
13. Effect of herpes simplex virus-1 gD or gD-IL-2 DNA vaccine on herpetic keratitis.
Inoue T; Inoue Y; Hayashi K; Shimomura Y; Fujisawa Y; Aono A; Tano Y
Cornea; 2002 Oct; 21(7 Suppl):S79-85. PubMed ID: 12484704
[TBL] [Abstract][Full Text] [Related]
14. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
[TBL] [Abstract][Full Text] [Related]
15. Recombinant vaccinia virus coexpressing the F protein of respiratory syncytial virus (RSV) and interleukin-4 (IL-4) does not inhibit the development of RSV-specific memory cytotoxic T lymphocytes, whereas priming is diminished in the presence of high levels of IL-2 or gamma interferon.
Bembridge GP; Lopez JA; Cook R; Melero JA; Taylor G
J Virol; 1998 May; 72(5):4080-7. PubMed ID: 9557697
[TBL] [Abstract][Full Text] [Related]
16. Role of CD8+ T cells and lymphoid dendritic cells in protection from ocular herpes simplex virus 1 challenge in immunized mice.
Matundan H; Mott KR; Ghiasi H
J Virol; 2014 Jul; 88(14):8016-27. PubMed ID: 24807710
[TBL] [Abstract][Full Text] [Related]
17. Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice.
Cui FD; Asada H; Jin ML; Kishida T; Shin-Ya M; Nakaya T; Kita M; Ishii M; Iwai M; Okanoue T; Imanishi J; Mazda O
Gene Ther; 2005 Jan; 12(2):160-8. PubMed ID: 15470476
[TBL] [Abstract][Full Text] [Related]
18. Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant.
Richards CM; Aman AT; Hirst TR; Hill TJ; Williams NA
J Virol; 2001 Feb; 75(4):1664-71. PubMed ID: 11160664
[TBL] [Abstract][Full Text] [Related]
19. Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection.
Morrison LA; Knipe DM
J Virol; 1994 Feb; 68(2):689-96. PubMed ID: 8289372
[TBL] [Abstract][Full Text] [Related]
20. Streptococcus pneumoniae fructose-1,6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1/Th2/Th17-type cytokine responses in mice.
Elhaik Goldman S; Dotan S; Talias A; Lilo A; Azriel S; Malka I; Portnoi M; Ohayon A; Kafka D; Ellis R; Elkabets M; Porgador A; Levin D; Azhari R; Swiatlo E; Ling E; Feldman G; Tal M; Dagan R; Mizrachi Nebenzahl Y
Int J Mol Med; 2016 Apr; 37(4):1127-38. PubMed ID: 26935978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]